D. E. Shaw & Co., Inc. Acrivon Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

  • $98.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
N/A
-14,811 Reduced 31.68%
31,939 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-160 Reduced 0.34%
46,750 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-14,986 Reduced 24.21%
46,910 $0
Q1 2023

May 15, 2023
BUY
N/A
61,896 New
61,896 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.7M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email